Skip to main content

Clinical Trials › NCT07477639

RecruitingPhase 1

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

Sponsored by Tr1X, Inc.

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
39
Target enrollment
2
U.S. states
Mar 2026
Start date
Jan 2029
Expected completion

Interventions / Treatments

TRX319Bendamustine

Conditions studied

Primary Progressive Multiple SclerosisSecondary Progressive Multiple Sclerosis (SPMS)Multiple SclerosisMultiple Sclerosis (MS) Primary ProgressiveMultiple Sclerosis (MS) Secondary Progressive

Where this trial is running (2 sites)

Kansas1 site
Kansas City
Missouri1 site
St Louis

Participating MS centers on MS Buddy (1)

MS centers in Kansas

Compare treatment centers near a trial site by center type, providers and trials.

View Kansas centers

More Phase 1 trials

Browse all Phase 1 MS trials
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play